Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://www.ajmc.com/view/high-dose-aflibercept-in-wet-amd-and-dme-provide-therapeutic-benefits-no-new-safety-signals
0
0
High-Dose Aflibercept in Wet AMD and DME Provide Therapeutic Benefits, No New Safety Signals - AJMC.com Managed Markets Network
2/12/23 at 1:35am
Organization
Ajmc.com
Authors
Laura Joszt
MA
57 words
0
Comments
Two studies looking at a higher dose of aflibercept found that an 8 mg dose can most be maintained at longer dosing intervals with similar benefits and no additional safety signals compared with the 2 mg dose.
Business & Industrial
Drugs & Medications
Aflibercept
Wet AMD
Safety Signals
DME Provide Therapeutic Benefits
Markets Network Two
dosing intervals
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...